About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Navy's 'significant bet' on a $13B supercarrier dogged as an expensive boondoggle while threats loom
- Jim Paulsen sees 'multiple years' before the next recession, and a pullback won't derail the S&P 500
- Tony Robbins shares a 2-step strategy for feeling more in control of your life
- 2017 Jaguar F-Pace 35t R-sport review: This luxury SUV is an absolute gamechanger
- This company is betting millennials will pay $30 to sit in a club and watch cat videos
NBR on TwitterMy Tweets
Subscribe to RSS
Fears of a death by Amazon may be overstated for a few resistant firms according to a team of Jefferies analysts.
Discretionary strategies generated 5.99% returns while computer strategies gained 3.17 percent in the first half of this year.
Netflix crushed subscriber estimates for the second quarter by adding 5.2 million members versus the Wall Street consensus of 3.2 million.
Morgan Stanley downgrades shares of Snap just 5 months after the firm helped take the once hot media stock public.
Goldman lowers its price target on Tesla shares, saying the company will likely have problems meeting its production targets this year.
“People would worry about trade wars and where we are going from there,” Art Cashin tells CNBC.
Cowen believes McDonald’s digital ordering upgrades will drive the fast-food chain’s sales higher.
Instinet has upped its target on Amazon’s stock to $1,100 from $975 a share.
The 74-year-old founder of Baron Capital says interest rates and oil prices will stay lower for “a very long time.”
Famed investor Paul Meeks says tech stocks are getting uncomfortably expensive.
Financial advisors say that before you buy ETFs, it’s important to grasp their nuances, because they are far from risk-free.
There are buying opportunities in biotech and drug stocks despite the backlash from the repeal of Obamacare.
The Inside ETF conference has begun, and by all accounts it is the biggest yet. Here’s what attendees will be talking about.
If the dollar keeps rising, investors may want to rethink consumer staples in their portfolios.
For investors looking to start 2017 with a bang, Netflix and Facebook might be the stocks to buy out of the so-called FANGs.